Literature DB >> 31186164

Elevated plasma cyclic guanosine monophosphate may explain greater efferent arteriolar tone in adults with longstanding type 1 diabetes: A brief report.

Petter Bjornstad1, Julie A Lovshin2, Yuliya Lytvyn3, Leif E Lovblom4, Daniel Scarr4, Geneviève Boulet4, Mohammed A Farooqi4, Andrej Orszag4, Johnny-Wei Bai4, Alanna Weisman4, Hillary A Keenan5, Michael H Brent6, Narinder Paul7, Vera Bril8, Bruce A Perkins9, David Z I Cherney3.   

Abstract

Cyclic guanosine monophosphate (cGMP) influences intrarenal hemodynamics in animal models, but the relationship between cGMP and renal function in adults with type 1 diabetes (T1D) remains unclear. In this study, plasma cGMP correlated with efferent arteriolar resistance, effective renal plasma flow, and renal vascular resistance in adults with T1D.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cyclic guanosine monophosphate; Diabetic kidney disease; Efferent arteriolar tone; Longstanding type 1 diabetes; Nitric oxide

Mesh：

Substances：

Year:  2019        PMID： 31186164      PMCID： PMC6613990          DOI： 10.1016/j.jdiacomp.2019.05.007

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN： 1056-8727            Impact factor:   2.852


  9 in total

Review 1.  Endothelium-derived vasoactive mediators and renal glomerular function.

Authors:  B J Ballermann; P A Marsden
Journal:  Clin Invest Med       Date:  1991-12       Impact factor: 0.825

2.  The effects of chronic hypoxia on renal function in the rat.

Authors:  M Neylon; J M Marshall; E J Johns
Journal:  J Physiol       Date:  1997-05-15       Impact factor: 5.182

3.  Natriuretic peptide receptors mediate different responses in rat renal microvessels.

Authors:  K Endlich; M Steinhausen
Journal:  Kidney Int       Date:  1997-07       Impact factor: 10.612

4.  Renin-angiotensin-aldosterone system activation in long-standing type 1 diabetes.

Authors:  Julie A Lovshin; Geneviève Boulet; Yuliya Lytvyn; Leif E Lovblom; Petter Bjornstad; Mohammed A Farooqi; Vesta Lai; Leslie Cham; Josephine Tse; Andrej Orszag; Daniel Scarr; Alanna Weisman; Hillary A Keenan; Michael H Brent; Narinder Paul; Vera Bril; Bruce A Perkins; David Zi Cherney
Journal:  JCI Insight       Date:  2018-01-11

5.  Impairment of the NO/cGMP pathway in the fasting and postprandial state in type 1 diabetes mellitus.

Authors:  K Farkas; G Jermendy; M Herold; E Ruzicska; M Sasvári; A Somogyi
Journal:  Exp Clin Endocrinol Diabetes       Date:  2004-05       Impact factor: 2.949

6.  Renal overexpression of atrial natriuretic peptide and hypoxia inducible factor-1α as adaptive response to a high salt diet.

Authors:  Silvana Lorena Della Penna; Gabriel Cao; Andrea Carranza; Elsa Zotta; Susana Gorzalczany; Carolina Susana Cerrudo; Natalia Lucía Rukavina Mikusic; Alicia Correa; Verónica Trida; Jorge Eduardo Toblli; María Inés Rosón; Belisario Enrique Fernández
Journal:  Biomed Res Int       Date:  2014-02-13       Impact factor: 3.411

7.  The effect of direct renin inhibition alone and in combination with ACE inhibition on endothelial function, arterial stiffness, and renal function in type 1 diabetes.

Authors:  David Z I Cherney; James W Scholey; Shan Jiang; Ronnie Har; Vesta Lai; Etienne B Sochett; Heather N Reich
Journal:  Diabetes Care       Date:  2012-07-26       Impact factor: 19.112

Review 8.  Guanylyl cyclase/natriuretic peptide receptor-A signaling antagonizes phosphoinositide hydrolysis, Ca(2+) release, and activation of protein kinase C.

Authors:  Kailash N Pandey
Journal:  Front Mol Neurosci       Date:  2014-08-22       Impact factor: 5.639

9.  Urinary cGMP predicts major adverse renal events in patients with mild renal impairment and/or diabetes mellitus before exposure to contrast medium.

Authors:  Lyubov Chaykovska; Fabian Heunisch; Gina von Einem; Carl-Friedrich Hocher; Oleg Tsuprykov; Mira Pavkovic; Peter Sandner; Axel Kretschmer; Chang Chu; Saban Elitok; Johannes-Peter Stasch; Berthold Hocher
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240
  9 in total
  1 in total

Review 1.  Role of sodium-glucose cotransporter 2 inhibition to mitigate diabetic kidney disease risk in type 1 diabetes.

Authors:  Daniël H van Raalte; Petter Bjornstad
Journal:  Nephrol Dial Transplant       Date:  2020-01-01       Impact factor: 5.992
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.